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In 1989 in his keynote address to the 21st Bethesda Confer- 
ence: Ethics in Cardiovascular Medicine (1), Dr. Sam Thief 
(then President of the Institute of Medicine) listed what he felt 
were the four primary responsibilities of the profession of 
medicine. These included 
1. the responsibility to maintain and transmit knowledge: 
2. the responsibility to act in the patient's interest; 
3. the responsibility to establish and enforce standards; and 
4. the responsibility to evaluate performance above rewards. 
We all feel comfortable with the implied ethical behavior 
inherent in each of these responsibilities. In fact, I believe that 
our ethical standards and behavior are a cut above most other 
professions in society, in part because of our trusted role to 
maximize both the physical and mental health of our patients. 
Contrast the above with what appears to be emerging asthe 
most important goal of for-profit health maintenance organi- 
zations (HMOs) and managed care organizations--the bottom 
line profit. As one views the multimillion dollar published 
salaries of chief executive otficers of these organizations and 
the attempt to maximize profit for investors, one is struck by 
the foreign nature of these goals compared with what we were 
taught in medical school. It's almost as if an alien culture has 
taken over medicine, and we must now learn their rules. These 
rules use -25% of medical costs for administration (2). These 
rules reward physicians for minimizing health care, diagnostic 
testing and therapeutic procedures and frequently punish them 
for "overutilization" of procedures. These rules will attempt to 
control us even more. 
For example, in a recent Credentials Committee Meeting of 
the American College of Cardiology, we r ceived an applica- 
tion from a candidate applying for membership who included 
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a letter that he had recently received from a large HMO/ 
managed care organization with which e was associated. After 
appropriate internal medicine and cardiology training, he 
passed the internal medicine boards of the American Board of 
Internal Medicine (ABIM) but had not yet passed the cardio- 
vascular boards. The letter indicated that because he was not 
board certified in cardiology he would be listed as an internist. 
Furthermore, the letter went on to say, "You may no longer 
perform or interpret non-invasive cardiology testing which 
includes echocardiograms and Doppler studies, nuclear cardi- 
ology wall motion, function, and perfusion studies, and vascu- 
lar ultrasound/duplex studies; you may no longer perform 
either diagnostic or therapeutic cardiac atheterization." Cer- 
tainly, the ABIM has never linked certification with hospital 
privileges. In truth, the two may have little relation with one 
another. Perhaps an HMO/managed care organization could 
refuse to pay for procedures done by non-board certified 
physicians, but the additional step of saying that they cannot do 
them seems to have crossed over the legal line. Another large 
group of interventional cardiologists reported the following to 
me. In a contract with one of the managed care groups, the 
company has indicated that only the two high volume inter- 
ventionalists can perform angioplasty, even though the rest of 
the group also meets the minimal ACC/American Heart 
Association standards for angioplasty. 
Unfortunately, in this environment, physicians will have to 
choose between what they believe is best for the patient and 
what they must do to survive. As the new breed of medical 
plans owned by wealthy investors underbids more established 
plans, there will be progressive cuts in services. Thi  is not 
dissimilar to an uncaring business hark in a hostile takeover. 
It hardly seems possible for our current ethical medical 
construct to survive. This will become specially acute when 
services are progressively cut. Because this whole process is 
market driven, it is unlikely to be easily reversed. However, 
medicine is not just a commodity. It carries with it a morality 
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(3) that may be destroyed by advertising hype and an emphasis 
only on the bottom line. It should be self-evident hat if 
community medicine is struggling to survive in this scenario, 
academic medical centers will be hardest hit. It will be impos- 
sible to maintain quality teaching at ll levels, together with all 
of the other missions of an academic center. 
What, then, are we to do? We must certainly never sacrifice 
our traditional ethical values for some modern plastic and cash 
values. We must remain advocates for our patients' health, and 
their right to choose their caregivers. The HMOs should 
certainly be held to high ethical standards, although it is 
unclear who would write such guidelines a d enforce them. 
Much of the political struggle in the near future will be related 
to Medicare and Medicaid. The American Medical Associa- 
tion's plan (4) has some general features of interest, including 
patient choice with igher out-of-pocket cost, or managed care 
or medical savings accounts. This would free doctors from 
Medicare price controls and even the playing field between 
fee-for-service physicians d large insurance company-run 
programs. 
Whatever the outcome with Medicare and the rest of health 
care, I hope that physicians can retain their high professional 
ethics against the bottom-line mentality of the for-profit com- 
panies. Unless humanism and professionalism remain, medi- 
cine will become just another commodity in life's marketplace. 
As such, it will be governed by advertising hype and the 
never-ending corporate goal to maximize profits. The concept 
of "quality" care will become so distorted as to be unrecogniz- 
able. Our patients deserve better than this--and so do we. 
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